AAAAAA
Results: 51-75/175
Authors:
COLLINS VP
Citation: Vp. Collins, PATHOLOGY AND BIOLOGICAL MARKERS, Bailliere's clinical neurology, 5(2), 1996, pp. 271-293
Authors:
KYRITSIS AP
YUNG WKA
Citation: Ap. Kyritsis et Wka. Yung, MOLECULAR-GENETICS AND TUMOR-SUPPRESSOR GENES IN GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 295-305
Authors:
WEINGART JD
LATERRA JJ
BREM H
Citation: Jd. Weingart et al., GROWTH-FACTORS AND ANGIOGENESIS, Bailliere's clinical neurology, 5(2), 1996, pp. 307-318
Authors:
BRADA M
ROSS G
Citation: M. Brada et G. Ross, RADIATION-THERAPY IN THE MANAGEMENT OF MALIGNANT GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 319-343
Authors:
ROSTOMILY RC
KELES GE
BERGER MS
Citation: Rc. Rostomily et al., RADICAL SURGERY IN THE MANAGEMENT OF LOW-GRADE AND HIGH-GRADE GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 345-369
Authors:
FORSYTH PAJ
CAIRNCROSS JG
Citation: Paj. Forsyth et Jg. Cairncross, CHEMOTHERAPY FOR MALIGNANT GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 371-393
Authors:
HOANGXUAN K
DELATTRE JY
Citation: K. Hoangxuan et Jy. Delattre, BIOLOGICAL AND MONOCLONAL-ANTIBODY THERAPY FOR HIGH-GRADE GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 395-411
Authors:
VIOLA JJ
MARTUZA RL
Citation: Jj. Viola et Rl. Martuza, GENE THERAPIES FOR GLIOBLASTOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 413-424
Authors:
WEITZNER MA
MEYERS CA
Citation: Ma. Weitzner et Ca. Meyers, QUALITY-OF-LIFE AND NEUROBEHAVIORAL FUNCTIONING IN PATIENTS WITH MALIGNANT GLIOMAS, Bailliere's clinical neurology, 5(2), 1996, pp. 425-439
Authors:
HARTUNG HP
KIEFER R
GOLD R
TOYKA KV
Citation: Hp. Hartung et al., AUTOIMMUNITY IN THE PERIPHERAL NERVOUS-SYSTEM, Bailliere's clinical neurology, 5(1), 1996, pp. 1-45
Authors:
HARTUNG HP
Citation: Hp. Hartung, PERIPHERAL NEUROPATHIES .2. PREFACE, Bailliere's clinical neurology, 5(1), 1996, pp. 9-9
Authors:
ARMATI PJ
POLLARD JD
Citation: Pj. Armati et Jd. Pollard, IMMUNOLOGY OF THE SCHWANN-CELL, Bailliere's clinical neurology, 5(1), 1996, pp. 47-64
Authors:
GRIFFIN JW
GEORGE EB
CHAUDHRY V
Citation: Jw. Griffin et al., WALLERIAN DEGENERATION IN PERIPHERAL-NERVE DISEASE, Bailliere's clinical neurology, 5(1), 1996, pp. 65-75
Authors:
SCHMALBRUCH H
KRARUP C
Citation: H. Schmalbruch et C. Krarup, ANIMAL-MODELS OF NEUROPATHIES, Bailliere's clinical neurology, 5(1), 1996, pp. 77-105
Authors:
CORNBLATH DR
Citation: Dr. Cornblath, THE ELECTROPHYSIOLOGY OF AXONAL AND DEMYELINATING POLYNEUROPATHIES, Bailliere's clinical neurology, 5(1), 1996, pp. 107-113
Authors:
BENECKE R
Citation: R. Benecke, MAGNETIC STIMULATION IN THE ASSESSMENT OF PERIPHERAL-NERVE DISORDERS, Bailliere's clinical neurology, 5(1), 1996, pp. 115-128
Authors:
STOLL G
Citation: G. Stoll, IMMUNOCYTOCHEMISTRY AS A DIAGNOSTIC-TOOL, Bailliere's clinical neurology, 5(1), 1996, pp. 129-142
Authors:
VALLAT JM
Citation: Jm. Vallat, ELECTRON-MICROSCOPY AS A TOOL TO DIAGNOSE NEUROPATHIES, Bailliere's clinical neurology, 5(1), 1996, pp. 143-156
Authors:
THOMAS PK
Citation: Pk. Thomas, UNDIAGNOSED NEUROPATHIES - THE IMPACT OF ANCILLARY INVESTIGATIONS, Bailliere's clinical neurology, 5(1), 1996, pp. 157-170
Authors:
WATERS MFR
JACOBS JM
Citation: Mfr. Waters et Jm. Jacobs, LEPROUS NEUROPATHIES, Bailliere's clinical neurology, 5(1), 1996, pp. 171-197
Authors:
DALAKAS MC
CUPLER EJ
Citation: Mc. Dalakas et Ej. Cupler, NEUROPATHIES IN HIV-INFECTION, Bailliere's clinical neurology, 5(1), 1996, pp. 199-218
Authors:
MIESCHER GC
STECK AJ
Citation: Gc. Miescher et Aj. Steck, PARAPROTEINEMIC NEUROPATHIES, Bailliere's clinical neurology, 5(1), 1996, pp. 219-232
Authors:
SLADKY JT
Citation: Jt. Sladky, IMMUNE NEUROPATHIES IN CHILDHOOD, Bailliere's clinical neurology, 5(1), 1996, pp. 233-244
Authors:
HARTUNG HP
Citation: Hp. Hartung, PERIPHERAL NEUROPATHIES .1. PREFACE, Bailliere's clinical neurology, 4(3), 1995, pp. 9-9
Authors:
HARDING AE
Citation: Ae. Harding, MOLECULAR-GENETICS OF PERIPHERAL NEUROPATHIES, Bailliere's clinical neurology, 4(3), 1995, pp. 383-400